DK584089D0 - Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstilling - Google Patents
Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstillingInfo
- Publication number
- DK584089D0 DK584089D0 DK584089A DK584089A DK584089D0 DK 584089 D0 DK584089 D0 DK 584089D0 DK 584089 A DK584089 A DK 584089A DK 584089 A DK584089 A DK 584089A DK 584089 D0 DK584089 D0 DK 584089D0
- Authority
- DK
- Denmark
- Prior art keywords
- quinuclidines
- medicine
- procedure
- preparation
- Prior art date
Links
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3839385A DE3839385A1 (de) | 1988-11-22 | 1988-11-22 | Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung |
DE3839385 | 1988-11-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK584089D0 true DK584089D0 (da) | 1989-11-21 |
DK584089A DK584089A (da) | 1990-05-23 |
DK170167B1 DK170167B1 (da) | 1995-06-06 |
Family
ID=6367625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK584089A DK170167B1 (da) | 1988-11-22 | 1989-11-21 | Quinuclidiner, deres anvendelse som lægemiddel og fremgangsmåde til deres fremstilling samt farmaceutisk præparat indeholdende en sådan forbindelse og fremgangsmåde til fremstilling af præparatet |
Country Status (18)
Country | Link |
---|---|
US (2) | US5451587A (da) |
EP (1) | EP0370415B1 (da) |
JP (1) | JPH0686449B2 (da) |
KR (1) | KR0165667B1 (da) |
AU (1) | AU628884B2 (da) |
BG (1) | BG61859B2 (da) |
CA (1) | CA2003422C (da) |
DE (3) | DE3839385A1 (da) |
DK (1) | DK170167B1 (da) |
ES (1) | ES2054988T3 (da) |
FI (1) | FI91637C (da) |
HU (1) | HU202527B (da) |
IE (1) | IE62328B1 (da) |
IL (1) | IL92377A (da) |
NO (1) | NO172801C (da) |
NZ (1) | NZ231445A (da) |
PT (1) | PT92368B (da) |
ZA (1) | ZA898858B (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
EP0492904A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted benzene derivatives for use in the treatment of glaucoma |
EP0492903A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
EP0492902A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyridine derivatives for use in the treatment of glaucoma |
ZA92278B (en) * | 1991-02-01 | 1992-10-28 | Akzo Nv | 3-quinuclidine derivatives |
GB9122988D0 (en) * | 1991-10-30 | 1991-12-18 | Ici Plc | Heterocyclic compounds |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
AU3901393A (en) * | 1992-04-10 | 1993-11-18 | Zeneca Limited | Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
GB9211796D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Heterocyclic derivatives |
GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
DE4236331A1 (de) * | 1992-10-28 | 1994-05-05 | Boehringer Ingelheim Kg | Synergistische Kombination |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5512574A (en) * | 1994-12-21 | 1996-04-30 | American Home Products Corporation | Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists |
DK0785198T3 (da) | 1996-01-19 | 2000-11-13 | Lonza Ag | Fremgangsmåde til fremstilling af optisk aktiv 3-quinuclidinol |
SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
CZ54498A3 (cs) * | 1997-03-07 | 1998-11-11 | Lonza Ag | Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití |
AU6896098A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Method for treating schizophrenia |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
DE10106971A1 (de) * | 2001-02-15 | 2002-08-29 | Boehringer Ingelheim Pharma | Arzneimittelformulierung die einen muskarinischen Agonisten enthält |
KR100448002B1 (ko) * | 2002-02-01 | 2004-09-13 | 한국과학기술연구원 | 신규한 퀴누클리딘 화합물 및 그 제조방법 |
KR20030083289A (ko) * | 2002-04-20 | 2003-10-30 | 한승호 | 다공질 화분 |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
EP1928437A2 (en) * | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2014831A1 (en) * | 1968-08-01 | 1970-04-24 | Sogeras | Quinuclidinyl and quinuclidinylalkyl ethers with cholino - lytic, antihistaminic and neurosedative activity |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-11-22 DE DE3839385A patent/DE3839385A1/de not_active Withdrawn
- 1988-11-22 DE DE8817121U patent/DE8817121U1/de not_active Expired - Lifetime
-
1989
- 1989-11-18 DE DE8989121387T patent/DE58904567D1/de not_active Expired - Lifetime
- 1989-11-18 EP EP89121387A patent/EP0370415B1/de not_active Expired - Lifetime
- 1989-11-18 ES ES89121387T patent/ES2054988T3/es not_active Expired - Lifetime
- 1989-11-20 KR KR1019890016802A patent/KR0165667B1/ko not_active IP Right Cessation
- 1989-11-20 NZ NZ231445A patent/NZ231445A/xx unknown
- 1989-11-21 CA CA002003422A patent/CA2003422C/en not_active Expired - Lifetime
- 1989-11-21 HU HU896032A patent/HU202527B/hu unknown
- 1989-11-21 ZA ZA898858A patent/ZA898858B/xx unknown
- 1989-11-21 DK DK584089A patent/DK170167B1/da not_active IP Right Cessation
- 1989-11-21 PT PT92368A patent/PT92368B/pt not_active IP Right Cessation
- 1989-11-21 JP JP1303037A patent/JPH0686449B2/ja not_active Expired - Lifetime
- 1989-11-21 IL IL9237789A patent/IL92377A/en not_active IP Right Cessation
- 1989-11-21 IE IE371289A patent/IE62328B1/en not_active IP Right Cessation
- 1989-11-21 FI FI895531A patent/FI91637C/fi active IP Right Grant
- 1989-11-21 NO NO894630A patent/NO172801C/no not_active IP Right Cessation
- 1989-11-22 AU AU45403/89A patent/AU628884B2/en not_active Expired
-
1994
- 1994-02-18 BG BG98490A patent/BG61859B2/bg unknown
- 1994-05-12 US US08/241,517 patent/US5451587A/en not_active Expired - Lifetime
-
1995
- 1995-06-16 US US08/491,463 patent/US5508405A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK584089D0 (da) | Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstilling | |
DK132789D0 (da) | 9-halogen-(z)-prostaglandinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel | |
NO881164L (no) | Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter. | |
DK381985D0 (da) | 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel | |
NO870666L (no) | Substituerte thienoinidasolderivater, fremgangsmaate til deres fremstilling og farmasoeytiske tilberedninger inneholdende disse og deres anvendelse som magesyresekresjonshemmer | |
DK209188A (da) | Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel | |
DK143284A (da) | Thiazolinderivater, deres fremstilling og anvendelse som laegemiddel | |
DK373787A (da) | Substituerede hydrazoner, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel | |
DK593883A (da) | Substituerede phenylsulfonyloxybenzimidazolcarbaminater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel | |
DK660788D0 (da) | 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel | |
DK168786A (da) | Hidtil ukendte dopaminderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel | |
NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
NO882112D0 (no) | Substituerte vinylcefalosporiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel. | |
NO890096D0 (no) | Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter. | |
DK506183D0 (da) | Hidtil ukendte carbacykliner, fremgangsmade til deres fremstilling og deres anvendelse som laegemiddel | |
DK403585D0 (da) | Histargin-beslaegtede forbindelser, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
DK627684D0 (da) | 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel | |
DK42888D0 (da) | Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel | |
DK120789A (da) | 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel | |
DK120889D0 (da) | 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter | |
NO822534L (no) | Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel | |
DK225189D0 (da) | Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
DK278290A (da) | Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler | |
DK547289A (da) | Benzoisothiazoler og fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel | |
DK184686D0 (da) | (aminoalkylthio)hydroxydibenzoxepiner, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |